Pharma IPR India 2012

Conference Day 31 January 2012
International Showcase 1-2 February 2012
Mumbai, India

Day-1 Agenda
  • Outlining the scope and current scenario of Patent law in USA and highlighting the critical areas to evaluate their adoption by the pharmaceutical companies in their business strategies
  • Analysing the Drug Price Competition and Patent Term Restoration Act - “Hatch- Waxman Act” to evaluate the relevant implications on the global pharmaceutical industry
  • Analysing the important factors in the Paragraph IV filing to assess the emerging trends of implementing it as a successful business strategy
  • Updating on the latest reforms in the US Patent system to formulate strategies for business growth and prepare for the increased competition
  • Highlighting the opportunities for Biosimilars and analysing the current patent trends to help avail strategic business benefits in the US markets
  • Analysing the European patent system to provide updated insights into the major developments in the pharmaceutical industry
  • Updating on the current scenario of Supplementary Protection Certificate (SPCs) in the European patent system to understand its implications on the pharmaceutical companies
  • Highlighting the opportunity available for biosimilars and analyzing the current trends within their patenting to help in availing strategic business benefits in the European markets
  • Evaluating the patentability standards in the pharmaceutical industry to mitigate the risks involved in product launches and analysing the freedom to Operate (FTO) by studying the various Infringement cases in European market

Parbuddha Ganguli,
Vision IPR, India

Komal Shah Bukhanwala,

Swati Veera,
Senior In-House Patent Attorney & Head-Patents
Piramal Life Sciences

Gopakumar G. Nair,
Gopakumar Nair Associates

Subramaniam Natarajan,
Subramaniam, Nataraj & Associates

Aaron F. Barkoff,Ph.D.,
McAndrews, Held & Malloy,USA
Register by calling Pallavi on +91 (022) 4046 1466 or emailing and and don't miss out an opportunity to overcome your legal challenges

No comments: